ANGIODYNAMICS, INC.
LATHAM, NY

Founded in Queensbury, New York, in 1988, AngioDynamics has become a key player in the medical device sector and is listed on the NASDAQ. The company boasts facilities in North America, Europe, and Asia, supporting around 1,400 employees worldwide. Its headquarters are at 14 Plaza Drive, Latham, NY, while maintaining an impressive market presence across over 50 countries. Originally focusing on interventional radiology research, AngioDynamics developed products like diagnostic catheters and thrombolytic delivery systems. After going public in May 2004 with the stock symbol ANGO, the company has significantly broadened its product range through strategic acquisitions such as RITA Medical Systems, Oncobionic, and Navilyst Medical. These moves have enriched their portfolio to include innovative solutions like radiofrequency ablation, vascular access products, angiographic equipment, dialysis systems, and targeted renal therapy. AngioDynamics is dedicated to innovation, aiming to provide leading-edge devices for minimally invasive treatment of peripheral vascular disease and other medical conditions. The company underscores the importance of ethical business practices by fostering trust, honesty, and continual improvement in its professional relationships. They are committed to exceptional customer service, superior product performance, and ongoing employee development. Despite challenges like a phishing scam in early 2018 involving fake job offers, AngioDynamics continues to focus on strategic growth. For more information or contact, visit their website at angiodynamics.com or reach out via international phone numbers. As an Equal Opportunity/Affirmative Action Employer, the company actively promotes diversity and inclusion in its workplace.